Transferable Exclusivity Vouchers and Incentives for Antimicrobial Development in the European Union
Journal of Law, Medicine & Ethics · 2023 · 51 (1) · 213-216
DOI: 10.1017/jme.2023.58 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Law, Medicine & Ethics, online erschienen am 25.05.2023. Verfasst von Victor L Van de Wiele und 3 weiteren Autor:innen. Beteiligte Einrichtung: PORTAL, HARVARD MEDICAL SCHOOL, BOSTON, MA, USA. Hauptthemen laut MEDLINE: Motivation, Anti-Infective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
The European Commission’s proposal to address antimicrobial resistance using transferable exclusivity vouchers (TEVs) is fundamentally flawed. European policymakers and regulators should consider alternatives, such as better funding for basic and clinical research, use of advance market commitments funded by a pay-or-play tax, or enacting an EU Fund for Antibiotic Development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PORTAL, HARVARD MEDICAL SCHOOL, BOSTON, MA, USA.
Zitieren
APA
Van de Wiele, V. L., Raymakers, A., Kesselheim, A. S., & Rome, B. N. (2023). Transferable Exclusivity Vouchers and Incentives for Antimicrobial Development in the European Union. Journal of Law, Medicine & Ethics, 51(1), 213-216. https://doi.org/10.1017/jme.2023.58
Vancouver
Van de Wiele VL, Raymakers A, Kesselheim AS, Rome BN. Transferable Exclusivity Vouchers and Incentives for Antimicrobial Development in the European Union. Journal of Law, Medicine & Ethics. 2023;51(1):213-216. doi:10.1017/jme.2023.58
BibTeX
@article{VandeWiele2023,
author = {Van de Wiele, Victor L and Raymakers, Adam and Kesselheim, Aaron S and Rome, Benjamin N},
title = {Transferable Exclusivity Vouchers and Incentives for Antimicrobial Development in the European Union},
journal = {Journal of Law, Medicine & Ethics},
year = {2023},
volume = {51},
number = {1},
pages = {213--216},
doi = {10.1017/jme.2023.58}
}
EUVIMED